Te­masek in­vests in ge­nomics firm

New Straits Times - - Business -

HONG KONG: A fund backed by Chi­nese bil­lion­aire Jack Ma and Sin­ga­pore’s state-owned in­vest­ment firm Te­masek Hold­ings Pte Ltd made new in­vest­ments in con­tract ge­nomics or­gan­i­sa­tion WuXi Nex­tCODE, which is ex­pand­ing in China as the coun­try pushes into the emerg­ing field of pre­ci­sion medicine.

Yun­feng Cap­i­tal and Te­masek co-led a US$75 mil­lion (RM324.75 mil­lion) Se­ries B round of fi­nanc­ing into the com­pany, said WuXi Nex­tCODE .

Other in­vestors in­clude Am­gen Ven­tures, a fund founded by Am­gen Inc, and pri­vate-eq­uity firm 3W Part­ners.

WuXi Nex­tCODE has of­fices in Shang­hai, Reyk­javik in Ice­land and Cam­bridge, Mas­sachusetts in the United States.

In China, it of­fers con­sumers ge­netic tests that are in­tended to un­cover de­tails such as the rare con­di­tion a child might be suf­fer­ing from or the risk of pass­ing on an in­her­ited dis­ease. Bloomberg

Newspapers in English

Newspapers from Malaysia

© PressReader. All rights reserved.